Low Risk for IBD Relapse After Switch From IV to Subcutaneous Infliximab French study showed low relapse rates across all intravenous dose regimens, except for one Aug 19, 2022
C-Section Babies Face Higher Crohn's Disease Risk Later in Life Underlying mechanism could be the gut microbiome, researcher hypothesizes Aug 17, 2022
What's the Best New Drug for Luminal Crohn's Disease? Meta-analysis ranks infliximab and others, but experts urge results are not ready for prime time Aug 04, 2022
Medical Trauma in Patients With IBD Hospitalizations, flares, and pain cited as sources of post-traumatic stress Aug 01, 2022
Improving Small Bowel Capsule Endoscopy Visualization Meta-analysis shows 15% improvement in adequate small bowel cleansing with purgative preparations Jul 26, 2022
TNF Inhibitors, Thiopurines May Help Reduce Recurrent Acute Arterial Events IBD patients with previous events saw lower risk of recurrence, according to French study Jul 19, 2022
Genotype Tied to Azathioprine Discontinuation for Toxicity Nearly threefold risk seen with a genotype most common among Black patients Jun 20, 2022
FDA OKs Risankizumab for Crohn's Disease Approval marks the third indication for the IL-23 inhibitor in adults Jun 17, 2022
Appendectomy Linked to Higher Risk of Microscopic Colitis Risk remained elevated over 10 years, Swedish study showed Jun 17, 2022
Biologics for Crohn's Go Head to Head Ustekinumab, adalimumab both effective in SEAVUE trial, with no difference in remissions Jun 13, 2022
Risankizumab Eases Moderate to Severe Crohn's Disease Induction and maintenance trials showed higher clinical remission with subcutaneous and IV doses Jun 06, 2022
Maintenance Mirikizumab Proves Mettle in Ulcerative Colitis In LUCENT-2, clinical remissions doubled among responders to induction therapy May 26, 2022
Etrasimod Shows Promise in Moderate to Severe Ulcerative Colitis Analysis of two ELEVATE trials showed significant improvements in clinical remission May 25, 2022
Antibiotics Heighten Risk for IBD in Seniors Registry-based study finds association with antibiotics that target gastrointestinal pathogens May 13, 2022
Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers? News and commentary from the world of gastroenterology and hepatology Apr 28, 2022
Perianal Fistulas in Crohn's Signal Greater Disease Burden U.S. registry finds greater medication use and twice as many IBD-related surgeries Apr 27, 2022
Pregnant Woman With Crohn's Disease Experiences Perianal Pain Pain may be sole symptom of Fournier's gangrene in the immunosuppressed Apr 25, 2022
Crohn's Fistulas Heal Better With Combined Surgical-TNF Blocker Approach Some, but not all, key outcomes prove better in clinical trial Apr 18, 2022
Pre-Op TNF Blockers Cleared of Infection Risk in IBD Patients Largest prospective cohort study finds no increase in postoperative infections Apr 14, 2022
Rinvoq Approved for UC; HCC Combo Flops; Disney Grants Pass to IBS Patient News and commentary from the world of gastroenterology and hepatology Mar 17, 2022
Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
Surveillance Colonoscopy in IBD Tied to Lower Advanced Cancer Risk Findings bolster guidelines for IBD patients with extensive colitis or left-sided colitis Mar 01, 2022
Ulcerative Colitis With an Unexpected Cause Can the immune response to COVID-19 trigger inflammatory bowel disease? Mar 01, 2022
SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Diet News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
Guselkumab Cuts Disease Activity in Crohn's Nearly two-thirds of patients respond to selective p19 IL-23 inhibitor Feb 08, 2022
Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
Simpler Tool Validated for Endoscopic Assessment in Crohn's SEMA-CD should be used as endpoint for clinical trials, researcher argues Jan 26, 2022
Vedolizumab for Ulcerative Colitis Works Best When Given Early Benefit confirmed in real-world data Jan 25, 2022
Combo Treatment Disappoints in Acute Severe Ulcerative Colitis No outcomes boost with addition of 5-ASA agent to corticosteroids in hospitalized patients Jan 23, 2022
Patients With IBD Cite Symptom Relief With Online Intervention Tool But experts warns that patients were on the very strict Specific Carbohydrate Diet Jan 22, 2022
Which IBD Patients Experience More Severe COVID? Research suggests immunomodulators, incomplete vaccination, and non-mRNA vaccines may play a role Jan 21, 2022
Crohn's Disease Scores With Interchangeable Humira Biosimilar "Non-medical switches" will be less of a concern when new treatment option becomes available Dec 31, 2021
Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patients Small pilot study found many children and young adults achieved clinical remission Dec 15, 2021
Year in Review: Crohn's Disease First interchangeable biosimilar approved, biologics go head-to-head Dec 15, 2021
For IBD Patients, Too Much Processed Meat May Be Deadly Study investigates diet's link to all-cause mortality, not just IBD incidence Dec 14, 2021
No Extra C. Diff Risk Observed With Vedolizumab in Ulcerative Colitis Retrospective study found no increased risk versus anti-TNF agents, but more research is needed Dec 11, 2021
Time Doesn't Heal Parents' Mental Health Wounds From Kids' IBD Dx "I was surprised" by these results, researcher says Dec 10, 2021
Biologics vs Small Molecule Drugs for UC: Which Agent Emerged on Top? The most effective drug not necessarily the safest Dec 01, 2021
JAK Inhibitor Maintenance Works in Severe Ulcerative Colitis Treatment group achieved clinical remission, met clinical secondary endpoints Oct 29, 2021
